Sopherion Therapeutics

Sopherion Therapeutics

closed

Sopherion has the US and Canadian rights to this liposomal nanotechnology that targets the tumor vasculature.

HQ location
New Brunswick, United States
Website
sopherion.com
Launch date
Employees
2-10 people
Enterprise value
$188—282m
https://www.linkedin.com/company/sopherion-therapeutics
    • Edit
loading funding rounds…
Sprout Group
Sprout Group
HealthCap
HealthCap
Canaan
Canaan
NewSpring Ventures
NewSpring Ventures
ProQuest
ProQuest
TL Ventures
TL Ventures
Seaflower Ventures
Seaflower Ventures
ProQuest Investments
ProQuest Investments
Johnson & Johnson Development Corporation
Johnson & Johnson Development Corporation
Connecticut Innovations
Connecticut Innovations
Intersouth Partners
Intersouth Partners
GE Capital Life Science and Technology Finance
GE Capital Life Science and Technology Finance
New Leaf Venture Partners
New Leaf Venture Partners
Zoticon BioVentures
Zoticon BioVentures
Devon Park BioVentures
Devon Park BioVentures
NewSpring Capital
NewSpring Capital

Related Content

Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Book a Demo